SCHEMBL6618680

SCHEMBL6618680

Clc1cccc(-c2cnc3cc4cn[nH]c4cc3n2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.50
MAPK1 P28482 1/20 0.46
TGFBR1 P36897 1/20 0.46
TGFBR2 P37173 1/20 0.46
NOS1 P29475 2/20 0.45
DYRK1A Q13627 1/20 0.45
IDO1 P14902 2/20 0.44
NUDT1 P36639 1/20 0.44
KDR P35968 2/20 0.42
JAK2 O60674 1/20 0.42
ROCK2 O75116 1/20 0.42
GSK3B P49841 1/20 0.42
AURKB Q96GD4 1/20 0.42
FGFR1 P11362 2/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PDGFRB P09619 1/20 0.41
FLT3 P36888 1/20 0.41
PIK3CA P42336 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6618137 1.00 CDC7 (0.50) CDC7MAPK1TGFBR1TGFBR2NOS1
SCHEMBL8112788 1.00 CDC7 (0.50) CDC7MAPK1TGFBR1TGFBR2NOS1
SCHEMBL6616714 0.86 MAPK1 (0.44) CDC7MAPK1TGFBR1TGFBR2NOS1
SCHEMBL6617657 0.86 MAPK1 (0.44) CDC7MAPK1TGFBR1TGFBR2NOS1
SCHEMBL6616738 0.85 SMN1; SMN2 (0.58) CDC7MAPK1DYRK1AKDRROCK2
SCHEMBL8111020 0.84 CDC7 (0.47) CDC7MAPK1TGFBR1IDO1NPC1
SCHEMBL6617130 0.84 BCHE (0.54) MAPK1TGFBR1IDO1KDRROCK2
SCHEMBL6617279 0.84 BCHE (0.54) CDC7MAPK1DYRK1AIDO1KDR
SCHEMBL6616183 0.84 EGFR (0.47) MAPK1NOS1DYRK1AIDO1KDR
SCHEMBL6617105 0.84 EGFR (0.47) MAPK1NOS1DYRK1AIDO1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE AVENTIS PHARMA INC (US) 2004-06-23 EP disclosed
US-5476851-A Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-12-19 US disclosed